730985-86-1

Usage

Uses

Used in Biochemical Research:
DABCYL-LYS-HCOV-SARS REPLICASE POLYPROTEIN 1AB (3235-3246)-GLU-EDANS is used as a research tool for studying the structure, function, and interactions of the SARS-CoV virus, particularly focusing on the replicase polyprotein 1ab.
Used in Diagnostic Testing:
In the field of diagnostic testing, DABCYL-LYS-HCOV-SARS REPLICASE POLYPROTEIN 1AB (3235-3246)-GLU-EDANS is used as a substrate in enzyme-linked immunosorbent assays (ELISAs) and other assays to detect the presence of antibodies or viral proteins associated with SARS-CoV infection. This aids in the identification and monitoring of SARS cases, contributing to effective disease management and control strategies.
Used in Pharmaceutical Development:
DABCYL-LYS-HCOV-SARS REPLICASE POLYPROTEIN 1AB (3235-3246)-GLU-EDANS may also be employed in the development of pharmaceuticals targeting SARS-CoV. By understanding the interactions between DABCYL-LYS-HCOV-SARS REPLICASE POLYPROTEIN 1AB (3235-3246)-GLU-EDANS and the virus, researchers can potentially develop therapeutic agents that interfere with viral replication or neutralize the virus, offering new treatment options for SARS patients.
Used in Vaccine Development:
In the context of vaccine development, DABCYL-LYS-HCOV-SARS REPLICASE POLYPROTEIN 1AB (3235-3246)-GLU-EDANS can be instrumental in designing vaccines that elicit an immune response against the SARS-CoV virus. By incorporating DABCYL-LYS-HCOV-SARS REPLICASE POLYPROTEIN 1AB (3235-3246)-GLU-EDANS into vaccine formulations, researchers can potentially enhance the body's ability to recognize and neutralize the virus, providing protection against SARS infections.